New patent for Eyenovia drug MYDCOMBI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MYDCOMBI
Annual Drug Patent Expirations for MYDCOMBI

Mydcombi is a drug marketed by Eyenovia and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

This drug has forty-four patent family members in fourteen countries.

The generic ingredient in MYDCOMBI is phenylephrine hydrochloride; tropicamide. One supplier is listed for this compound. Additional details are available on the phenylephrine hydrochloride; tropicamide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top